{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:53:43Z","timestamp":1775804023689,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.vaccine.2010.11.057","type":"journal-article","created":{"date-parts":[[2010,12,5]],"date-time":"2010-12-05T09:15:00Z","timestamp":1291540500000},"page":"1017-1022","source":"Crossref","is-referenced-by-count":26,"title":["Immunogenicity and reactogenicity of co-administered tetanus\u2013diphtheria\u2013acellular pertussis (Tdap) and tetravalent meningococcal conjugate (MCV4) vaccines compared to their separate administration"],"prefix":"10.1016","volume":"29","author":[{"given":"Wayde M.","family":"Weston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard R.","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Howe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"RR-3","key":"10.1016\/j.vaccine.2010.11.057_bib0005","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"RR07","key":"10.1016\/j.vaccine.2010.11.057_bib0010","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the advisory committee on immunization practices (ACIP)","volume":"54","author":"Bilukha","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2010.11.057_bib0015","unstructured":"Notice to Readers: Revised recommendations of the advisory committee on immunization practices to vaccinate all persons aged 11\u201318 years with meningococcal conjugate vaccine. MMWR 2007; 56(31):794\u20135."},{"issue":"3","key":"10.1016\/j.vaccine.2010.11.057_bib0020","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1542\/peds.2005-3038","article-title":"Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine","volume":"117","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2010.11.057_bib0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.1996.03530250041024","article-title":"Efficacy of acellular pertussis vaccine in early childhood after household exposure","volume":"275","author":"Schmitt","year":"1996","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2010.11.057_bib0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis","volume":"334","author":"Greco","year":"1996","journal-title":"N Engl J Med"},{"issue":"RR15","key":"10.1016\/j.vaccine.2010.11.057_bib0035","first-page":"1","article-title":"General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2010.11.057_bib0040","series-title":"Vaccines","first-page":"139","article-title":"Diphtheria toxoid","author":"Vitek","year":"2008"},{"key":"10.1016\/j.vaccine.2010.11.057_bib0045","series-title":"Seminars in infectious disease: bacteria vaccines","first-page":"380","article-title":"Role of antibody to filamentous hemagglutinin and to leukocytosis promoting factor-hemagglutinin in immunity to pertussis","author":"Sato","year":"1982"},{"issue":"1","key":"10.1016\/j.vaccine.2010.11.057_bib0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF02097184","article-title":"Acellular pertussis vaccine in adults: adverse reactions and immune response","volume":"6","author":"Granstr\u00f6m","year":"1987","journal-title":"Eur J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.11.057_bib0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.11.057_bib0060","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from post-licensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diag Lab Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.11.057_bib0065","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines for the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2010.11.057_bib0070","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1542\/peds.2005-1759","article-title":"Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents","volume":"117","author":"Pichichero","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2010.11.057_bib0075","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.vaccine.2008.11.028","article-title":"Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19\u201364 years of age","volume":"27","author":"Blatter","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2010.11.057_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/hv.9961","article-title":"Safety and immunogenicity of a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine when co-administered with influenza vaccine in adults","volume":"5","author":"Weston","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2010.11.057_bib0085","unstructured":"Study NCT00777257; http:\/\/clinicaltrials.gov. [accessed 26.04.10]."},{"key":"10.1016\/j.vaccine.2010.11.057_bib0090","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2010.02.045","article-title":"Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines","volume":"28","author":"Arguedas","year":"2010","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2010.11.057_bib0095","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1016\/j.vaccine.2008.04.055","article-title":"Current issues in adolescent immunization","volume":"26","author":"Brabin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.057_bib0100","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/01.inf.0000166161.12087.94","article-title":"Challenges to vaccinating adolescents: vaccine implementation issues","volume":"24","author":"Humiston","year":"2005","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10016919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10016919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T10:01:52Z","timestamp":1592128912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10016919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0264410X10016919"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.11.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}